by Mike Thurogood, CMktr | Mar 19, 2026 | In Silico & Data Insights, Leadscope, Press Releases
3/18/2026 – Boston, MA; Staffordshire, UK – Instem, a global leader in SaaS solutions for life sciences R&D, today announced a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA). (Q)SAR models...
by Mike Thurogood, CMktr | Nov 4, 2025 | Company News, Press Releases
As part of our continued commitment to delivering world-class software solutions for R&D that drive discovery, accelerate studies and advance your research, we are unifying the Xybion, RockStep Solutions, Autoscribe Informatics, and Strong Tower Solutions teams...
by Mike Thurogood, CMktr | Jun 13, 2025 | Company News
Instem is pleased to announce the opening of our new office in Smartworks 43EQ, a landmark facility in Balewadi, Pune. The opening was celebrated with an inauguration event attended by Instem CEO, Vik Krishnan. This move marks a significant milestone in our journey to...
by Mike Thurogood, CMktr | Apr 17, 2025 | Press Releases
17 April 2025 – Boston, MA & Staffordshire, UK – Following the FDA’s recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as the industry’s trusted provider of an end-to-end preclinical platform –...
by Mike Thurogood, CMktr | Mar 27, 2025 | Meet the Experts
Artificial Intelligence is rapidly reshaping industries across the globe — and life sciences is no exception. As the pace of innovation accelerates, the potential for AI to enhance drug discovery, streamline study management, and transform regulatory submissions is...
